Trial intelligence / Profile preview

Nano-fortified Bleaching Gel on Tooth Whitening and Hypersensitivity

NCT06904118Completed

Sponsor
Pakistan Institute of Medical Sciences
Start
Jun 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of titanium dioxide nanoparticles in tooth discoloration and dentin hypersensitivity (DH) (2 arms), sponsored by Pakistan Institute of Medical Sciences. Primary endpoint: Post-bleaching sensitivity at 3 months. Started Jun 2024; status: completed.

02

Drugs

titanium dioxide nanoparticles
03

Conditions

tooth discolorationdentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT06904118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06904118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call